It is now weli established that defects in fibrillin-l (FBNl) cause the variable and pleiotropic features of Marfan syndrome (MFS) and, at the most severe end of its clinical spectrum, neonatal Marfan syndrome (nMFS). Patients with nMFS have mitral and tricuspid valve involvement and aortic root dilatation, and die of congestive heart failure, often in the first year of life. Although mutations in classical MFS have been observed along the entire length of the FBN1 mRNA, mutations in nMFS appear to cluster in a relatively small region of FBN1, approximately between exons 24 and 34. Here we describe the appearance of two FBN1 mutations in a single allele of an infant with nMFS. The changes were within six bases of each other in exon 26. One was a T3212G transversion resulting in an I1071S amino acid substitution and the second was an A3219T transversion resulting in an E1073D amino acid substitution. This is the first reported double mutant allele in FBN1. (7Med Genet 1996;33:760-763) 
Cloning and sequencing was performed as previously described.25
Results Genomic DNA, amplified with intron primers to exon 26, showed heteroduplex formation when run on an MDE gel ( fig 1A) . Direct sequencing of the amplified fragment showed two nucleotide substitutions (data not shown). In order to determine whether both changes were on a single allele, the amplicon was cloned and subsequently sequenced. Sequence analysis of the clones showed that both the T32 1 2G and A32 1 9T transversions were on the same FBN1 allele ( fig 1B) . The former mutation resulted in an I1071S amino acid substitution and the latter transversion resulted in an E1073D amino acid substitution. Study of the parents confirmed that neither harboured any of the mutations (data not shown). Studies using several highly informative markers were also consistent with paternity. The patient reported here had the typical cardiovascular features seen in nMFS, but also had dextrocardia. There are three major causes of dextrocardia: (1) situs inversus, a mirror image inversion of all the normally asymmetrical structures; (2) dextroversion, failure of the cardiac apex to rotate from right to left; and (3) dextroposition, a mechanical shift of the heart to the right owing to either a mass effect in the left chest or lack of normal lung volume in the right chest.37 Echocardiograms and plain chest and abdominal radiographs showed the position of the liver, spleen, stomach, and heart in our patient. The cardiac situs was determined to be solitus (atria were in the correct right-left orientation). Also, there was no abdominal heterotaxia. This finding rules out laterality disorders, such as Kartagener syndrome and the asplenia and polysplenia disorders. We believe this patient had dextroposition secondary to her severely misshapen thoracic cage, despite the raised right hemidiaphragm. Unfortunately, no necropsy was performed that would have confirmed this suspicion.
Although many hundreds of CFTR mutations have been reported,38 from the thousands of CF patients screened, few double mutant alleles have been identified. Savov et all correctly point out that once the common mutations have been identified in patients screening stops. It is indeed possible that if the entire CFTR was screened in all CF patients, additional double mutant alleles would be uncovered. Since almost all MFS patients and families have unique FBN1 mutations, most protocols call for the screening of the entire coding region and flanking splice junctions. The recent publication of intron primer pairs for all 65 FBN1 exons has greatly aided the effort to identify mutations in MFS patients and in those with overlapping phenotypes.30
In our routine screening through the neonatal region first and subsequently the entire complement of the remaining FBN1 exons, we identified a nMFS patient with two changes in FBN1. Since the initial sequencing was performed directly from PCR amplicons, we were unsure whether both changes were in the same allele. Cloning of the PCR products showed that both changes were in a single allele. We thank Drs L James Maher III and Simon Sherman for helpful discussions and James D Birrell and Joe Edwards for excellent photographic assistance. This work was supported in part by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health HL48126 (MG) and a Clinical Research Grant 6-FY94-0012 from the March of Dimes Birth Defects Foundation (MG). MG is an Established Investigator of the American Heart Association (funding was contributed in part by the AHA Florida Affiliate).
